Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atherosclerosis | 61 | 2019 | 693 | 7.070 |
Why?
|
Diabetes Mellitus, Type 2 | 58 | 2019 | 1379 | 5.550 |
Why?
|
Cardiovascular Diseases | 52 | 2019 | 1013 | 5.330 |
Why?
|
Heart Failure | 30 | 2019 | 568 | 4.760 |
Why?
|
Ethnic Groups | 50 | 2019 | 440 | 3.270 |
Why?
|
African Americans | 40 | 2018 | 1373 | 3.000 |
Why?
|
Aged, 80 and over | 109 | 2019 | 3717 | 3.000 |
Why?
|
Middle Aged | 170 | 2019 | 10829 | 2.970 |
Why?
|
Diabetes Mellitus | 27 | 2019 | 366 | 2.940 |
Why?
|
Aged | 157 | 2019 | 9487 | 2.890 |
Why?
|
Risk Factors | 100 | 2019 | 3531 | 2.770 |
Why?
|
Female | 173 | 2019 | 18164 | 2.410 |
Why?
|
United States | 83 | 2019 | 3630 | 2.310 |
Why?
|
Male | 168 | 2019 | 17807 | 2.290 |
Why?
|
Insulin Resistance | 15 | 2019 | 449 | 2.220 |
Why?
|
Blood Glucose | 22 | 2019 | 466 | 2.220 |
Why?
|
Humans | 195 | 2019 | 29093 | 2.150 |
Why?
|
Diabetic Angiopathies | 10 | 2019 | 137 | 2.110 |
Why?
|
Incidence | 51 | 2018 | 1119 | 1.960 |
Why?
|
Body Mass Index | 30 | 2019 | 865 | 1.850 |
Why?
|
Diet | 12 | 2017 | 354 | 1.850 |
Why?
|
Obesity | 24 | 2018 | 1063 | 1.780 |
Why?
|
Hypertension | 20 | 2019 | 906 | 1.700 |
Why?
|
Myocardial Infarction | 9 | 2019 | 412 | 1.650 |
Why?
|
Risk Assessment | 25 | 2019 | 1305 | 1.600 |
Why?
|
Diabetes Complications | 9 | 2018 | 171 | 1.590 |
Why?
|
Proportional Hazards Models | 31 | 2018 | 709 | 1.530 |
Why?
|
Coronary Artery Disease | 17 | 2018 | 359 | 1.510 |
Why?
|
Residence Characteristics | 12 | 2018 | 181 | 1.470 |
Why?
|
European Continental Ancestry Group | 34 | 2018 | 1131 | 1.460 |
Why?
|
Blood Pressure | 17 | 2019 | 804 | 1.390 |
Why?
|
Primary Health Care | 7 | 2009 | 178 | 1.350 |
Why?
|
Waist Circumference | 11 | 2018 | 89 | 1.320 |
Why?
|
Natriuretic Peptide, Brain | 6 | 2017 | 57 | 1.270 |
Why?
|
Cohort Studies | 38 | 2019 | 1687 | 1.230 |
Why?
|
Stroke Volume | 10 | 2019 | 278 | 1.160 |
Why?
|
Prevalence | 30 | 2019 | 896 | 1.150 |
Why?
|
Continental Population Groups | 14 | 2017 | 221 | 1.130 |
Why?
|
Triglycerides | 8 | 2018 | 214 | 1.120 |
Why?
|
Coronary Disease | 8 | 2019 | 200 | 1.080 |
Why?
|
Prospective Studies | 39 | 2019 | 2019 | 1.060 |
Why?
|
Peptide Fragments | 6 | 2017 | 422 | 1.020 |
Why?
|
Calcinosis | 14 | 2017 | 143 | 0.990 |
Why?
|
Menopause | 2 | 2015 | 86 | 0.960 |
Why?
|
Life Style | 14 | 2018 | 364 | 0.950 |
Why?
|
Prediabetic State | 4 | 2018 | 54 | 0.940 |
Why?
|
Motor Activity | 6 | 2015 | 310 | 0.940 |
Why?
|
Postmenopause | 5 | 2018 | 397 | 0.910 |
Why?
|
Socioeconomic Factors | 11 | 2019 | 391 | 0.890 |
Why?
|
Adult | 40 | 2019 | 8420 | 0.850 |
Why?
|
Cross-Sectional Studies | 25 | 2019 | 1356 | 0.840 |
Why?
|
C-Reactive Protein | 9 | 2016 | 232 | 0.840 |
Why?
|
Stroke | 4 | 2017 | 545 | 0.820 |
Why?
|
Hispanic Americans | 26 | 2016 | 904 | 0.800 |
Why?
|
Heart Ventricles | 8 | 2018 | 107 | 0.800 |
Why?
|
Ventricular Dysfunction, Left | 6 | 2017 | 136 | 0.800 |
Why?
|
Follow-Up Studies | 24 | 2019 | 2108 | 0.790 |
Why?
|
Population Surveillance | 2 | 2019 | 119 | 0.770 |
Why?
|
Exercise | 13 | 2017 | 591 | 0.750 |
Why?
|
Fasting | 9 | 2019 | 93 | 0.740 |
Why?
|
Ventricular Remodeling | 3 | 2018 | 52 | 0.730 |
Why?
|
Healthcare Disparities | 3 | 2017 | 153 | 0.720 |
Why?
|
Sex Factors | 13 | 2018 | 631 | 0.720 |
Why?
|
Guideline Adherence | 7 | 2009 | 110 | 0.720 |
Why?
|
Asian Americans | 17 | 2015 | 98 | 0.710 |
Why?
|
Cholesterol | 5 | 2017 | 229 | 0.710 |
Why?
|
Overweight | 9 | 2016 | 256 | 0.700 |
Why?
|
Hypertrophy, Left Ventricular | 7 | 2018 | 105 | 0.700 |
Why?
|
Hyperlipidemias | 3 | 2009 | 50 | 0.700 |
Why?
|
Myocardial Contraction | 1 | 2019 | 55 | 0.690 |
Why?
|
Age Factors | 14 | 2019 | 1108 | 0.690 |
Why?
|
Lipids | 6 | 2019 | 209 | 0.680 |
Why?
|
Multivariate Analysis | 14 | 2018 | 637 | 0.670 |
Why?
|
Atrial Fibrillation | 3 | 2017 | 311 | 0.670 |
Why?
|
Geographic Information Systems | 2 | 2017 | 14 | 0.640 |
Why?
|
Coronary Vessels | 5 | 2018 | 147 | 0.620 |
Why?
|
Body Height | 1 | 2017 | 30 | 0.620 |
Why?
|
Models, Statistical | 2 | 2017 | 163 | 0.620 |
Why?
|
Health Status | 2 | 2017 | 368 | 0.620 |
Why?
|
Evaluation Studies as Topic | 1 | 2017 | 39 | 0.600 |
Why?
|
African Continental Ancestry Group | 12 | 2019 | 350 | 0.590 |
Why?
|
Calcium | 7 | 2018 | 296 | 0.580 |
Why?
|
Cholesterol, LDL | 8 | 2018 | 157 | 0.570 |
Why?
|
North Carolina | 13 | 2016 | 1423 | 0.570 |
Why?
|
Time Factors | 18 | 2019 | 2001 | 0.560 |
Why?
|
Mass Screening | 2 | 2009 | 223 | 0.540 |
Why?
|
Health Services Accessibility | 3 | 2017 | 231 | 0.540 |
Why?
|
Menopause, Premature | 1 | 2015 | 8 | 0.530 |
Why?
|
Inflammation | 5 | 2013 | 507 | 0.530 |
Why?
|
Practice Guidelines as Topic | 5 | 2019 | 374 | 0.520 |
Why?
|
Estrogen Replacement Therapy | 1 | 2016 | 182 | 0.520 |
Why?
|
Cardiomyopathies | 3 | 2008 | 48 | 0.520 |
Why?
|
Medicare | 4 | 2005 | 186 | 0.510 |
Why?
|
Risk Reduction Behavior | 7 | 2017 | 116 | 0.500 |
Why?
|
Adiposity | 8 | 2018 | 191 | 0.490 |
Why?
|
Environment Design | 3 | 2017 | 13 | 0.490 |
Why?
|
Albuminuria | 5 | 2017 | 176 | 0.480 |
Why?
|
Glucose Intolerance | 2 | 2012 | 44 | 0.460 |
Why?
|
Walking | 3 | 2016 | 177 | 0.460 |
Why?
|
Health Promotion | 2 | 2013 | 220 | 0.450 |
Why?
|
Weight Loss | 7 | 2016 | 413 | 0.450 |
Why?
|
Electrocardiography | 6 | 2018 | 562 | 0.440 |
Why?
|
Primary Prevention | 4 | 2019 | 47 | 0.440 |
Why?
|
Ventricular Function, Left | 5 | 2018 | 194 | 0.430 |
Why?
|
Urban Population | 1 | 2013 | 79 | 0.430 |
Why?
|
Cause of Death | 10 | 2019 | 220 | 0.430 |
Why?
|
Hypercholesterolemia | 3 | 2010 | 59 | 0.420 |
Why?
|
Young Adult | 11 | 2019 | 2402 | 0.420 |
Why?
|
Algorithms | 1 | 2015 | 462 | 0.410 |
Why?
|
Food | 1 | 2011 | 41 | 0.410 |
Why?
|
Body Weight | 4 | 2018 | 290 | 0.400 |
Why?
|
Longitudinal Studies | 16 | 2018 | 720 | 0.400 |
Why?
|
Magnetic Resonance Imaging | 14 | 2018 | 1218 | 0.400 |
Why?
|
Prognosis | 13 | 2018 | 1362 | 0.390 |
Why?
|
Antihypertensive Agents | 7 | 2019 | 339 | 0.390 |
Why?
|
Hydrocortisone | 3 | 2018 | 61 | 0.380 |
Why?
|
Managed Care Programs | 3 | 2005 | 38 | 0.370 |
Why?
|
Comorbidity | 8 | 2019 | 540 | 0.370 |
Why?
|
Feeding Behavior | 6 | 2016 | 159 | 0.360 |
Why?
|
American Heart Association | 4 | 2019 | 84 | 0.360 |
Why?
|
Predictive Value of Tests | 11 | 2017 | 787 | 0.350 |
Why?
|
Health Status Disparities | 4 | 2018 | 113 | 0.350 |
Why?
|
Actigraphy | 3 | 2018 | 11 | 0.350 |
Why?
|
Retrospective Studies | 12 | 2019 | 3111 | 0.350 |
Why?
|
Mississippi | 6 | 2019 | 24 | 0.350 |
Why?
|
Morbidity | 5 | 2019 | 91 | 0.350 |
Why?
|
Tunica Intima | 6 | 2014 | 59 | 0.350 |
Why?
|
Chi-Square Distribution | 7 | 2017 | 293 | 0.350 |
Why?
|
Cholesterol, HDL | 5 | 2018 | 165 | 0.340 |
Why?
|
Social Environment | 5 | 2018 | 75 | 0.340 |
Why?
|
Anticholesteremic Agents | 1 | 2009 | 36 | 0.330 |
Why?
|
Asian Continental Ancestry Group | 5 | 2013 | 110 | 0.320 |
Why?
|
Medicaid | 3 | 2005 | 83 | 0.320 |
Why?
|
Aortic Diseases | 3 | 2017 | 54 | 0.310 |
Why?
|
Genome-Wide Association Study | 5 | 2018 | 543 | 0.310 |
Why?
|
Quality Assurance, Health Care | 2 | 2005 | 61 | 0.300 |
Why?
|
Physical Fitness | 3 | 2015 | 119 | 0.300 |
Why?
|
Survival Analysis | 5 | 2016 | 440 | 0.300 |
Why?
|
Obesity, Abdominal | 2 | 2018 | 23 | 0.300 |
Why?
|
Environment | 2 | 2017 | 51 | 0.300 |
Why?
|
Tomography, X-Ray Computed | 10 | 2017 | 871 | 0.290 |
Why?
|
Aldosterone | 2 | 2017 | 28 | 0.290 |
Why?
|
Sleep | 2 | 2018 | 86 | 0.290 |
Why?
|
Carotid Arteries | 6 | 2014 | 97 | 0.280 |
Why?
|
Renin | 2 | 2017 | 112 | 0.280 |
Why?
|
Area Under Curve | 6 | 2017 | 85 | 0.270 |
Why?
|
Hospitalization | 4 | 2016 | 417 | 0.270 |
Why?
|
Electronic Health Records | 2 | 2017 | 118 | 0.270 |
Why?
|
Troponin T | 2 | 2017 | 57 | 0.270 |
Why?
|
Angina, Unstable | 1 | 2005 | 17 | 0.270 |
Why?
|
Dyslipidemias | 3 | 2013 | 52 | 0.270 |
Why?
|
Interleukin-6 | 5 | 2015 | 225 | 0.270 |
Why?
|
Tunica Media | 5 | 2014 | 29 | 0.260 |
Why?
|
Food Supply | 2 | 2016 | 53 | 0.260 |
Why?
|
Lung | 2 | 2017 | 233 | 0.260 |
Why?
|
Sex Distribution | 4 | 2017 | 186 | 0.260 |
Why?
|
Diabetic Retinopathy | 2 | 2017 | 64 | 0.250 |
Why?
|
Testosterone | 2 | 2018 | 47 | 0.250 |
Why?
|
Logistic Models | 7 | 2018 | 727 | 0.250 |
Why?
|
Estradiol | 2 | 2018 | 118 | 0.240 |
Why?
|
Hypoglycemic Agents | 5 | 2019 | 176 | 0.240 |
Why?
|
Anthropometry | 2 | 2016 | 82 | 0.240 |
Why?
|
Coronary Artery Bypass | 1 | 2004 | 100 | 0.230 |
Why?
|
Linear Models | 7 | 2016 | 426 | 0.230 |
Why?
|
Demography | 2 | 2016 | 104 | 0.230 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2017 | 464 | 0.220 |
Why?
|
Risk | 8 | 2017 | 289 | 0.220 |
Why?
|
Polysomnography | 2 | 2018 | 32 | 0.200 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 298 | 0.200 |
Why?
|
Carotid Artery Diseases | 4 | 2014 | 109 | 0.200 |
Why?
|
Dietary Fats | 2 | 2012 | 108 | 0.200 |
Why?
|
Aorta | 2 | 2014 | 103 | 0.200 |
Why?
|
Genetic Variation | 3 | 2018 | 251 | 0.200 |
Why?
|
Energy Intake | 2 | 2019 | 120 | 0.190 |
Why?
|
Social Support | 2 | 2018 | 163 | 0.180 |
Why?
|
Aortic Valve | 3 | 2011 | 47 | 0.180 |
Why?
|
Stress, Psychological | 3 | 2018 | 208 | 0.180 |
Why?
|
Qualitative Research | 2 | 2018 | 142 | 0.170 |
Why?
|
Acculturation | 2 | 2016 | 16 | 0.170 |
Why?
|
Circadian Rhythm | 3 | 2018 | 43 | 0.170 |
Why?
|
Arrhythmias, Cardiac | 2 | 2017 | 79 | 0.170 |
Why?
|
Regression Analysis | 8 | 2012 | 274 | 0.170 |
Why?
|
Health Behavior | 4 | 2016 | 214 | 0.170 |
Why?
|
Leptin | 2 | 2016 | 66 | 0.170 |
Why?
|
Disabled Persons | 2 | 2017 | 83 | 0.170 |
Why?
|
Myocardium | 2 | 2018 | 170 | 0.170 |
Why?
|
Lipoprotein(a) | 1 | 2018 | 10 | 0.170 |
Why?
|
Health Resources | 1 | 2018 | 33 | 0.170 |
Why?
|
Arteriosclerosis | 3 | 2008 | 116 | 0.170 |
Why?
|
Models, Theoretical | 2 | 2016 | 126 | 0.170 |
Why?
|
Disclosure | 1 | 2018 | 36 | 0.170 |
Why?
|
Coronary Angiography | 2 | 2016 | 136 | 0.170 |
Why?
|
Adiponectin | 2 | 2016 | 103 | 0.160 |
Why?
|
Fibroblast Growth Factors | 1 | 2018 | 34 | 0.160 |
Why?
|
Hyperglycemia | 2 | 2009 | 82 | 0.160 |
Why?
|
Kidney Diseases | 2 | 2013 | 239 | 0.160 |
Why?
|
Heart Failure, Diastolic | 1 | 2018 | 15 | 0.160 |
Why?
|
Depression | 3 | 2018 | 380 | 0.160 |
Why?
|
Nutrigenomics | 1 | 2017 | 2 | 0.160 |
Why?
|
Ankle Brachial Index | 3 | 2018 | 37 | 0.160 |
Why?
|
Heart Arrest | 1 | 2017 | 39 | 0.160 |
Why?
|
Kidney Failure, Chronic | 2 | 2017 | 518 | 0.150 |
Why?
|
Renal Insufficiency | 1 | 2017 | 53 | 0.150 |
Why?
|
Aorta, Abdominal | 1 | 2017 | 26 | 0.150 |
Why?
|
Caregivers | 1 | 2018 | 94 | 0.150 |
Why?
|
Social Class | 1 | 2017 | 78 | 0.150 |
Why?
|
Dyspnea | 1 | 2017 | 30 | 0.150 |
Why?
|
Pulmonary Emphysema | 1 | 2016 | 8 | 0.150 |
Why?
|
Edema, Cardiac | 1 | 2016 | 13 | 0.150 |
Why?
|
Cost of Illness | 1 | 2017 | 63 | 0.150 |
Why?
|
Insulin | 3 | 2017 | 346 | 0.150 |
Why?
|
Heart | 1 | 2018 | 161 | 0.150 |
Why?
|
Depressive Disorder, Major | 1 | 2017 | 35 | 0.150 |
Why?
|
Sleep Deprivation | 1 | 2016 | 7 | 0.150 |
Why?
|
Patient Selection | 2 | 2016 | 257 | 0.150 |
Why?
|
Reproducibility of Results | 6 | 2017 | 726 | 0.150 |
Why?
|
Arizona | 1 | 2016 | 7 | 0.140 |
Why?
|
Severity of Illness Index | 6 | 2018 | 863 | 0.140 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2005 | 59 | 0.140 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 126 | 0.140 |
Why?
|
Body Fat Distribution | 1 | 2016 | 34 | 0.140 |
Why?
|
Metabolic Diseases | 2 | 2013 | 17 | 0.140 |
Why?
|
Patient Education as Topic | 3 | 2012 | 251 | 0.140 |
Why?
|
Bradycardia | 1 | 2016 | 15 | 0.140 |
Why?
|
Pituitary-Adrenal System | 2 | 2013 | 24 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 5 | 2018 | 836 | 0.140 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2013 | 34 | 0.140 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2005 | 134 | 0.140 |
Why?
|
Smoking | 6 | 2016 | 427 | 0.140 |
Why?
|
Activities of Daily Living | 1 | 2017 | 238 | 0.140 |
Why?
|
Insulin-Secreting Cells | 1 | 2016 | 53 | 0.140 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 268 | 0.140 |
Why?
|
Caloric Restriction | 1 | 2016 | 92 | 0.140 |
Why?
|
Self Care | 1 | 2016 | 137 | 0.130 |
Why?
|
Obesity, Morbid | 1 | 2016 | 55 | 0.130 |
Why?
|
Fibrinogen | 3 | 2010 | 42 | 0.130 |
Why?
|
Saliva | 2 | 2013 | 36 | 0.130 |
Why?
|
Vegetables | 2 | 2012 | 35 | 0.130 |
Why?
|
Air Pollution | 1 | 2015 | 17 | 0.130 |
Why?
|
Air Pollutants | 1 | 2015 | 20 | 0.130 |
Why?
|
Mortality | 1 | 2016 | 109 | 0.130 |
Why?
|
Echocardiography, Stress | 1 | 2015 | 22 | 0.130 |
Why?
|
Fruit | 2 | 2012 | 53 | 0.130 |
Why?
|
Behavior Therapy | 1 | 2015 | 89 | 0.130 |
Why?
|
Attitude to Health | 1 | 2016 | 148 | 0.130 |
Why?
|
Lipoproteins | 1 | 2015 | 82 | 0.130 |
Why?
|
Xanthophylls | 1 | 2014 | 3 | 0.120 |
Why?
|
Lutein | 1 | 2014 | 4 | 0.120 |
Why?
|
Recurrence | 1 | 2015 | 235 | 0.120 |
Why?
|
Renin-Angiotensin System | 1 | 2016 | 182 | 0.120 |
Why?
|
Cardiac Surgical Procedures | 1 | 2015 | 71 | 0.120 |
Why?
|
Health Services | 1 | 2014 | 35 | 0.120 |
Why?
|
Environmental Exposure | 1 | 2015 | 87 | 0.120 |
Why?
|
Macular Degeneration | 1 | 2014 | 21 | 0.120 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2014 | 52 | 0.120 |
Why?
|
Health Care Costs | 1 | 2014 | 108 | 0.120 |
Why?
|
Age Distribution | 3 | 2016 | 198 | 0.120 |
Why?
|
Inpatients | 1 | 2013 | 64 | 0.110 |
Why?
|
Emigrants and Immigrants | 1 | 2016 | 235 | 0.110 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2012 | 2 | 0.110 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2012 | 8 | 0.110 |
Why?
|
Hyperlipidemia, Familial Combined | 2 | 2010 | 3 | 0.110 |
Why?
|
Dietary Supplements | 1 | 2014 | 170 | 0.110 |
Why?
|
Calcaneus | 1 | 2012 | 13 | 0.110 |
Why?
|
Survival Rate | 4 | 2017 | 795 | 0.110 |
Why?
|
Disease Progression | 5 | 2013 | 572 | 0.110 |
Why?
|
Counseling | 1 | 2012 | 85 | 0.110 |
Why?
|
Secondary Prevention | 1 | 2012 | 59 | 0.110 |
Why?
|
Diet, Mediterranean | 1 | 2012 | 23 | 0.110 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2012 | 10 | 0.110 |
Why?
|
Genetic Loci | 1 | 2012 | 147 | 0.110 |
Why?
|
Iron, Dietary | 1 | 2012 | 11 | 0.110 |
Why?
|
Restaurants | 1 | 2011 | 7 | 0.100 |
Why?
|
Health Status Indicators | 1 | 2012 | 67 | 0.100 |
Why?
|
Catecholamines | 1 | 2011 | 17 | 0.100 |
Why?
|
Heart Rate | 1 | 2014 | 315 | 0.100 |
Why?
|
Poisson Distribution | 2 | 2018 | 14 | 0.100 |
Why?
|
Fatty Acids | 1 | 2012 | 92 | 0.100 |
Why?
|
Zinc | 1 | 2012 | 32 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2012 | 1079 | 0.100 |
Why?
|
Focus Groups | 1 | 2011 | 103 | 0.100 |
Why?
|
Case-Control Studies | 3 | 2015 | 859 | 0.100 |
Why?
|
Minority Groups | 2 | 2016 | 69 | 0.100 |
Why?
|
Analysis of Variance | 4 | 2015 | 454 | 0.100 |
Why?
|
Bone Density | 1 | 2012 | 182 | 0.100 |
Why?
|
Individuality | 1 | 2010 | 5 | 0.100 |
Why?
|
Body Composition | 1 | 2013 | 365 | 0.100 |
Why?
|
Sensitivity and Specificity | 2 | 2009 | 532 | 0.100 |
Why?
|
Ventricular Function, Right | 1 | 2010 | 15 | 0.100 |
Why?
|
Diabetic Nephropathies | 2 | 2019 | 195 | 0.090 |
Why?
|
Nutrition Surveys | 2 | 2008 | 134 | 0.090 |
Why?
|
Adipose Tissue | 2 | 2009 | 327 | 0.090 |
Why?
|
Computers, Handheld | 1 | 2009 | 7 | 0.090 |
Why?
|
Chlamydophila Infections | 1 | 2009 | 2 | 0.090 |
Why?
|
Hepatitis A | 1 | 2009 | 4 | 0.090 |
Why?
|
Aorta, Thoracic | 1 | 2009 | 72 | 0.090 |
Why?
|
Helicobacter Infections | 1 | 2009 | 10 | 0.090 |
Why?
|
Herpes Simplex | 1 | 2009 | 12 | 0.090 |
Why?
|
Homeostasis | 1 | 2009 | 127 | 0.090 |
Why?
|
Drug Utilization | 1 | 2009 | 47 | 0.090 |
Why?
|
Cytomegalovirus Infections | 1 | 2009 | 25 | 0.090 |
Why?
|
Probability | 1 | 2009 | 150 | 0.090 |
Why?
|
Cystatins | 1 | 2008 | 8 | 0.080 |
Why?
|
Creatinine | 3 | 2017 | 174 | 0.080 |
Why?
|
Family Practice | 1 | 2009 | 46 | 0.080 |
Why?
|
Glucose Tolerance Test | 2 | 2018 | 125 | 0.080 |
Why?
|
Chronic Disease | 2 | 2014 | 369 | 0.080 |
Why?
|
Monitoring, Physiologic | 1 | 2009 | 68 | 0.080 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 40 | 0.080 |
Why?
|
Organ Size | 3 | 2018 | 196 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2009 | 180 | 0.080 |
Why?
|
Blood Pressure Determination | 1 | 2008 | 94 | 0.080 |
Why?
|
Sex Characteristics | 3 | 2018 | 167 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 130 | 0.080 |
Why?
|
Health Personnel | 1 | 2009 | 111 | 0.080 |
Why?
|
Reserpine | 1 | 2007 | 3 | 0.080 |
Why?
|
Delivery of Health Care | 1 | 2009 | 142 | 0.080 |
Why?
|
Goals | 1 | 2007 | 36 | 0.080 |
Why?
|
Interviews as Topic | 1 | 2008 | 249 | 0.070 |
Why?
|
Patient Participation | 1 | 2007 | 62 | 0.070 |
Why?
|
Physicians, Family | 1 | 2006 | 14 | 0.070 |
Why?
|
Professional Practice | 1 | 2006 | 23 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2006 | 35 | 0.070 |
Why?
|
Heart Valve Diseases | 1 | 2006 | 25 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2006 | 52 | 0.070 |
Why?
|
Aging | 1 | 2012 | 881 | 0.070 |
Why?
|
Drug Utilization Review | 1 | 2005 | 17 | 0.070 |
Why?
|
Southeastern United States | 1 | 2005 | 71 | 0.070 |
Why?
|
Syndrome | 1 | 2005 | 66 | 0.070 |
Why?
|
ROC Curve | 2 | 2016 | 149 | 0.070 |
Why?
|
Adolescent | 3 | 2015 | 3254 | 0.070 |
Why?
|
Safety | 2 | 2016 | 72 | 0.070 |
Why?
|
Dehydroepiandrosterone | 2 | 2018 | 10 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2006 | 162 | 0.060 |
Why?
|
Sex Hormone-Binding Globulin | 2 | 2018 | 14 | 0.060 |
Why?
|
Alleles | 2 | 2018 | 251 | 0.060 |
Why?
|
Acute Disease | 1 | 2005 | 239 | 0.060 |
Why?
|
Likelihood Functions | 1 | 2004 | 39 | 0.060 |
Why?
|
Crystallography, X-Ray | 1 | 2004 | 77 | 0.060 |
Why?
|
Total Quality Management | 1 | 2004 | 19 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2005 | 176 | 0.060 |
Why?
|
Lung Diseases | 1 | 2004 | 45 | 0.060 |
Why?
|
Patient Discharge | 1 | 2005 | 168 | 0.060 |
Why?
|
Medical Records | 1 | 2004 | 68 | 0.060 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2018 | 64 | 0.060 |
Why?
|
Indians, North American | 1 | 2004 | 108 | 0.060 |
Why?
|
Glomerular Filtration Rate | 2 | 2017 | 287 | 0.060 |
Why?
|
Databases, Factual | 2 | 2015 | 332 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2004 | 96 | 0.060 |
Why?
|
Eating | 2 | 2015 | 73 | 0.060 |
Why?
|
Proteins | 1 | 2004 | 140 | 0.060 |
Why?
|
Heart Diseases | 1 | 2004 | 97 | 0.060 |
Why?
|
Genotype | 2 | 2017 | 735 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2016 | 3099 | 0.060 |
Why?
|
Stents | 1 | 2004 | 171 | 0.060 |
Why?
|
Carotid Artery, Internal | 3 | 2007 | 29 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2004 | 222 | 0.050 |
Why?
|
Meat | 2 | 2012 | 15 | 0.050 |
Why?
|
Databases as Topic | 1 | 2002 | 24 | 0.050 |
Why?
|
Ultrasonography | 3 | 2010 | 345 | 0.050 |
Why?
|
China | 2 | 2015 | 44 | 0.050 |
Why?
|
Reference Values | 2 | 2012 | 224 | 0.050 |
Why?
|
Neoplasms | 1 | 2007 | 610 | 0.050 |
Why?
|
Cystatin C | 2 | 2012 | 28 | 0.050 |
Why?
|
Carbohydrate Metabolism | 1 | 2018 | 13 | 0.040 |
Why?
|
Sex Ratio | 1 | 2018 | 1 | 0.040 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2019 | 24 | 0.040 |
Why?
|
Radiography | 2 | 2010 | 353 | 0.040 |
Why?
|
Patients | 1 | 2018 | 46 | 0.040 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2018 | 47 | 0.040 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2018 | 48 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 273 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 1 | 2018 | 28 | 0.040 |
Why?
|
Extracellular Space | 1 | 2018 | 25 | 0.040 |
Why?
|
Diet Records | 1 | 2017 | 31 | 0.040 |
Why?
|
Diastole | 1 | 2018 | 90 | 0.040 |
Why?
|
Fibrosis | 1 | 2018 | 102 | 0.040 |
Why?
|
Preventive Health Services | 1 | 2017 | 30 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2018 | 190 | 0.040 |
Why?
|
Waist-Hip Ratio | 1 | 2017 | 33 | 0.040 |
Why?
|
Multicenter Studies as Topic | 2 | 2009 | 92 | 0.040 |
Why?
|
Echocardiography | 1 | 2017 | 140 | 0.040 |
Why?
|
Systole | 2 | 2009 | 87 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2017 | 92 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 1 | 2016 | 23 | 0.040 |
Why?
|
Vital Capacity | 1 | 2016 | 44 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 2016 | 112 | 0.040 |
Why?
|
Community Health Services | 1 | 2016 | 54 | 0.040 |
Why?
|
Models, Cardiovascular | 1 | 2016 | 27 | 0.040 |
Why?
|
Odds Ratio | 2 | 2010 | 447 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 159 | 0.040 |
Why?
|
Cardiovascular System | 1 | 2016 | 39 | 0.040 |
Why?
|
Poverty | 1 | 2016 | 99 | 0.030 |
Why?
|
Nutrition Policy | 1 | 2015 | 33 | 0.030 |
Why?
|
Phenotype | 1 | 2017 | 629 | 0.030 |
Why?
|
Forecasting | 1 | 2016 | 133 | 0.030 |
Why?
|
Nitrogen Oxides | 1 | 2015 | 5 | 0.030 |
Why?
|
Blood Urea Nitrogen | 1 | 2015 | 12 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 120 | 0.030 |
Why?
|
Particle Size | 1 | 2015 | 42 | 0.030 |
Why?
|
Baltimore | 1 | 2015 | 49 | 0.030 |
Why?
|
Particulate Matter | 1 | 2015 | 30 | 0.030 |
Why?
|
Lipoproteins, VLDL | 1 | 2015 | 27 | 0.030 |
Why?
|
Germany | 1 | 2014 | 8 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2015 | 80 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2014 | 52 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2014 | 165 | 0.030 |
Why?
|
Brugada Syndrome | 1 | 2014 | 17 | 0.030 |
Why?
|
Brachial Artery | 1 | 2014 | 66 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2015 | 150 | 0.030 |
Why?
|
Vasodilation | 1 | 2014 | 87 | 0.030 |
Why?
|
Heart Conduction System | 1 | 2014 | 69 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2013 | 24 | 0.030 |
Why?
|
Nuts | 1 | 2012 | 4 | 0.030 |
Why?
|
Fishes | 1 | 2012 | 7 | 0.030 |
Why?
|
Insulin-Like Growth Factor Binding Protein 4 | 1 | 2012 | 1 | 0.030 |
Why?
|
Psychotherapy, Group | 1 | 2012 | 15 | 0.030 |
Why?
|
Remission Induction | 1 | 2012 | 78 | 0.030 |
Why?
|
Poultry | 1 | 2012 | 29 | 0.030 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2012 | 20 | 0.030 |
Why?
|
India | 1 | 2012 | 61 | 0.030 |
Why?
|
Dairy Products | 1 | 2012 | 12 | 0.030 |
Why?
|
Diet Surveys | 1 | 2012 | 56 | 0.030 |
Why?
|
Hospital Mortality | 1 | 2013 | 186 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2015 | 247 | 0.030 |
Why?
|
Cattle | 1 | 2012 | 100 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2012 | 54 | 0.030 |
Why?
|
Vitamin E | 1 | 2012 | 21 | 0.030 |
Why?
|
Micronutrients | 1 | 2012 | 15 | 0.030 |
Why?
|
Microcirculation | 1 | 2011 | 61 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 155 | 0.030 |
Why?
|
Heme | 1 | 2012 | 60 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 816 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2012 | 211 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 200 | 0.020 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2010 | 4 | 0.020 |
Why?
|
Animals | 2 | 2012 | 7297 | 0.020 |
Why?
|
Mobility Limitation | 1 | 2012 | 187 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 493 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2015 | 670 | 0.020 |
Why?
|
Cardiac Volume | 1 | 2009 | 11 | 0.020 |
Why?
|
Cardiac Output | 1 | 2009 | 32 | 0.020 |
Why?
|
Educational Status | 1 | 2010 | 164 | 0.020 |
Why?
|
Hepatitis A Virus, Human | 1 | 2009 | 1 | 0.020 |
Why?
|
Simplexvirus | 1 | 2009 | 3 | 0.020 |
Why?
|
Chlamydophila pneumoniae | 1 | 2009 | 4 | 0.020 |
Why?
|
Seroepidemiologic Studies | 1 | 2009 | 9 | 0.020 |
Why?
|
Helicobacter pylori | 1 | 2009 | 9 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 2009 | 20 | 0.020 |
Why?
|
Aortic Valve Stenosis | 1 | 2009 | 28 | 0.020 |
Why?
|
Health Surveys | 1 | 2009 | 191 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2008 | 106 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2009 | 104 | 0.020 |
Why?
|
Contrast Media | 1 | 2008 | 123 | 0.020 |
Why?
|
Education, Medical | 1 | 2008 | 67 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2009 | 134 | 0.020 |
Why?
|
Gender Identity | 1 | 2007 | 18 | 0.020 |
Why?
|
SEER Program | 1 | 2007 | 32 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2007 | 28 | 0.020 |
Why?
|
Pilot Projects | 1 | 2009 | 469 | 0.020 |
Why?
|
Homocysteine | 1 | 2007 | 15 | 0.020 |
Why?
|
Drinking | 1 | 2007 | 10 | 0.020 |
Why?
|
Mexican Americans | 1 | 2007 | 59 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2007 | 60 | 0.020 |
Why?
|
Carotid Artery, Common | 1 | 2007 | 37 | 0.020 |
Why?
|
Community Networks | 1 | 2006 | 26 | 0.020 |
Why?
|
Medical Audit | 1 | 2005 | 14 | 0.020 |
Why?
|
Motivation | 1 | 2006 | 102 | 0.020 |
Why?
|
Social Justice | 1 | 2005 | 17 | 0.020 |
Why?
|
Research Design | 1 | 2007 | 286 | 0.020 |
Why?
|
Diuretics | 1 | 2005 | 22 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2005 | 55 | 0.020 |
Why?
|
Spironolactone | 1 | 2005 | 11 | 0.020 |
Why?
|
Crystallization | 1 | 2004 | 16 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2004 | 140 | 0.020 |
Why?
|
Equipment Design | 1 | 2004 | 167 | 0.010 |
Why?
|
Data Collection | 1 | 2004 | 163 | 0.010 |
Why?
|
Robotics | 1 | 2004 | 122 | 0.010 |
Why?
|